White JM - Search Results

1

A comparison of antagonist-precipitated withdrawal under anesthesia to standard inpatient withdrawal as a precursor to maintenance naltrexone treatment in heroin users: outcomes at 6 and 12 months.

McGregor C, Ali R, White JM, Thomas P, Gowing L. McGregor C, et al. Among authors: white jm. Drug Alcohol Depend. 2002 Sep 1;68(1):5-14. doi: 10.1016/s0376-8716(02)00077-7. Drug Alcohol Depend. 2002. PMID: 12167548 Clinical Trial.

2

Buprenorphine versus methadone maintenance: a cost-effectiveness analysis.

Doran CM, Shanahan M, Mattick RP, Ali R, White J, Bell J. Doran CM, et al. Drug Alcohol Depend. 2003 Sep 10;71(3):295-302. doi: 10.1016/s0376-8716(03)00169-8. Drug Alcohol Depend. 2003. PMID: 12957347

3

Antagonist-precipitated heroin withdrawal under anaesthetic prior to maintenance naltrexone treatment: determinants of withdrawal severity.

Ali R, Thomas P, White J, McGregor C, Danz C, Gowing L, Stegink A, Athanasos P. Ali R, et al. Drug Alcohol Rev. 2003 Dec;22(4):425-31. doi: 10.1080/09595230310001613949. Drug Alcohol Rev. 2003. PMID: 14660132 Clinical Trial.

4

Buprenorphine for the management of opioid withdrawal.

Gowing L, Ali R, White JM. Gowing L, et al. Among authors: white jm. Cochrane Database Syst Rev. 2009 Jul 8;(3):CD002025. doi: 10.1002/14651858.CD002025.pub4. Cochrane Database Syst Rev. 2009. Update in: Cochrane Database Syst Rev. 2017 Feb 21;2:CD002025. doi: 10.1002/14651858.CD002025.pub5 PMID: 19588330 Updated. Review.

5

Opioid antagonists with minimal sedation for opioid withdrawal.

Gowing L, Ali R, White JM. Gowing L, et al. Among authors: white jm. Cochrane Database Syst Rev. 2009 Oct 7;(4):CD002021. doi: 10.1002/14651858.CD002021.pub3. Cochrane Database Syst Rev. 2009. Update in: Cochrane Database Syst Rev. 2017 May 29;5:CD002021. doi: 10.1002/14651858.CD002021.pub4 PMID: 19821290 Updated. Review.

6

Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal.

Gowing L, Ali R, White JM. Gowing L, et al. Among authors: white jm. Cochrane Database Syst Rev. 2010 Jan 20;2010(1):CD002022. doi: 10.1002/14651858.CD002022.pub3. Cochrane Database Syst Rev. 2010. PMID: 20091529 Free PMC article. Review.

7

Buprenorphine for managing opioid withdrawal.

Gowing L, Ali R, White JM, Mbewe D. Gowing L, et al. Among authors: white jm. Cochrane Database Syst Rev. 2017 Feb 21;2(2):CD002025. doi: 10.1002/14651858.CD002025.pub5. Cochrane Database Syst Rev. 2017. PMID: 28220474 Free PMC article. Review.

8

Opioid antagonists with minimal sedation for opioid withdrawal.

Gowing L, Ali R, White JM. Gowing L, et al. Among authors: white jm. Cochrane Database Syst Rev. 2017 May 29;5(5):CD002021. doi: 10.1002/14651858.CD002021.pub4. Cochrane Database Syst Rev. 2017. PMID: 28553701 Free PMC article. Review.

9

Alpha2-adrenergic agonists in opioid withdrawal.

Gowing LR, Farrell M, Ali RL, White JM. Gowing LR, et al. Among authors: white jm. Addiction. 2002 Jan;97(1):49-58. doi: 10.1046/j.1360-0443.2002.00037.x. Addiction. 2002. PMID: 11895270 Review.

10

Relationship between LAAM-methadone preference and treatment outcomes.

White JM, Danz C, Kneebone J, La Vincente SF, Newcombe DA, Ali RL. White JM, et al. Drug Alcohol Depend. 2002 May 1;66(3):295-301. doi: 10.1016/s0376-8716(02)00007-8. Drug Alcohol Depend. 2002. PMID: 12062464 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,297 results

Search Page

Filters